Atom | Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Funder: National Institutes of Health

Funding Amounts: Up to $450,000 direct costs over 3 years; no more than $225,000 in any single year; project period up to 3 years.

Summary: Supports pilot studies to develop and test novel or adapted interventions for HIV prevention, treatment, or program implementation among people who use substances, requiring a clinical trial.

Key Information: Clinical trial is required; meaningful engagement of end users/community experts is mandatory; foreign organizations are eligible.

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Sign in to see full grant listing